Bococizumab (Anti-PCSK9)
Product Specifications
CAS Number
1407495-02-6
Synonyms
PF-04950615; RN316
Target
PCSK9
Applications
Metabolism
Additionnal Information
Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS001911-100ug 100 µg
PHC1 (NM_004426) Human Over-expression Lysate
Sign In for Pricing
View Details 
GTR15365317 1 Vial
Lentiviral human OR4D10 sgRNA gene knockout kit - Lentiviral human OR4D10 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 
MBS6315548-01 0.2 mL
LCP1, ID (LCP1, PLS2, Plastin-2, L-plastin, LC64P, Lymphocyte cytosolic protein 1) (APC)
Sign In for Pricing
View Details MBS6315548-02 5x 0.2 mL
LCP1, ID (LCP1, PLS2, Plastin-2, L-plastin, LC64P, Lymphocyte cytosolic protein 1) (APC)
Sign In for Pricing
View Details